PureTech Health plc
PRTC.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £507 | £677 | £901 | £1,132 |
| - Cash | £281 | £191 | £150 | £466 |
| + Debt | £159 | £25 | £47 | £53 |
| Enterprise Value | £385 | £511 | £798 | £719 |
| Revenue | £4 | £1 | £2 | £10 |
| % Growth | 475.3% | -64.1% | -79.1% | – |
| Gross Profit | £4 | -£93 | -£137 | -£100 |
| % Margin | 100% | -12,387.3% | -6,546.2% | -1,007% |
| EBITDA | £37 | -£18 | -£80 | -£47 |
| % Margin | 866.3% | -2,357.5% | -3,824.7% | -470.5% |
| Net Income | £54 | -£66 | -£50 | -£61 |
| % Margin | 1,240.1% | -8,759.6% | -2,409.3% | -606.9% |
| EPS Diluted | 0.2 | -0.24 | -0.18 | -0.21 |
| % Growth | 183.3% | -33.3% | 14.3% | – |
| Operating Cash Flow | -£134 | -£106 | -£179 | -£158 |
| Capital Expenditures | -£0 | -£0 | -£2 | -£6 |
| Free Cash Flow | -£134 | -£106 | -£181 | -£164 |